Poulin YP - Search Results

1

A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris.

Webster GF, Guenther L, Poulin YP, Solomon BA, Loven K, Lee J. Webster GF, et al. Among authors: poulin yp. Cutis. 2002 Feb;69(2 Suppl):4-11. Cutis. 2002. PMID: 12095066 Clinical Trial.

2

Topical retinoids in the treatment of acne vulgaris.

Bershad S, Poulin YP, Berson DS, Sabean J, Brodell RT, Shalita AR, Kakita L, Tanghetti E, Leyden J, Webster GF, Miller BH. Bershad S, et al. Among authors: poulin yp. Cutis. 1999 Aug;64(2 Suppl):8-20; quiz 21-3. Cutis. 1999. PMID: 10472493 Review. No abstract available.

3

Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of scalp psoriasis.

Poulin Y, Papp K, Bissonnette R, Guenther L, Tan J, Lynde C, Kerrouche N, Villemagne H; CalePso Study Team. Poulin Y, et al. Cutis. 2010 Jan;85(1):43-50. Cutis. 2010. PMID: 20184211 Clinical Trial.

4

A comparison of tazarotene 0.1% gel once daily plus mometasone furoate 0.1% cream once daily versus calcipotriene 0.005% ointment twice daily in the treatment of plaque psoriasis.

Guenther LC, Poulin YP, Pariser DM. Guenther LC, et al. Among authors: poulin yp. Clin Ther. 2000 Oct;22(10):1225-38. doi: 10.1016/s0149-2918(00)83065-9. Clin Ther. 2000. PMID: 11110233 Clinical Trial.

5

A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne.

Gold LS, Tan J, Cruz-Santana A, Papp K, Poulin Y, Schlessinger J, Gidner J, Liu Y, Graeber M; Adapalene-BPO Study Group. Gold LS, et al. Cutis. 2009 Aug;84(2):110-6. Cutis. 2009. PMID: 19746769 Clinical Trial.

6

Topical treatment of actinic keratoses with 3.0% diclofenac in 2.5% hyaluronan gel.

Rivers JK, Arlette J, Shear N, Guenther L, Carey W, Poulin Y. Rivers JK, et al. Br J Dermatol. 2002 Jan;146(1):94-100. doi: 10.1046/j.1365-2133.2002.04561.x. Br J Dermatol. 2002. PMID: 11841372 Clinical Trial.

7

Off-Label Use of Topical Calcineurin Inhibitors in Dermatologic Disorders.

Guenther L, Lynde C, Poulin Y. Guenther L, et al. J Cutan Med Surg. 2019 Sep/Oct;23(4_suppl):27S-34S. doi: 10.1177/1203475419857668. J Cutan Med Surg. 2019. PMID: 31476936 Review.

8

Ixekizumab Results in Persistent Clinical Improvement in Moderate-to-Severe Genital Psoriasis During a 52 Week, Randomized, Placebo-Controlled, Phase 3 Clinical Trial.

Guenther L, Potts Bleakman A, Weisman J, Poulin Y, Spelman L, Burge R, Erickson J, Todd K, Bertram CC, Ryan C. Guenther L, et al. Acta Derm Venereol. 2020 Jan 7;100(1):adv00006. doi: 10.2340/00015555-3353. Acta Derm Venereol. 2020. PMID: 31620802 Free PMC article. Clinical Trial.

9

Integrating biologic agents into management of moderate-to-severe psoriasis: a consensus of the Canadian Psoriasis Expert Panel. February 27, 2004.

Guenther L, Langley RG, Shear NH, Bissonnette R, Ho V, Lynde C, Murray E, Papp K, Poulin Y, Zip C. Guenther L, et al. J Cutan Med Surg. 2004 Sep-Oct;8(5):321-37. doi: 10.1007/s10227-005-0035-1. J Cutan Med Surg. 2004. PMID: 15868311

10

Adapalene gel 0.3% for the treatment of acne vulgaris: a multicenter, randomized, double-blind, controlled, phase III trial.

Thiboutot D, Pariser DM, Egan N, Flores J, Herndon JH Jr, Kanof NB, Kempers SE, Maddin S, Poulin YP, Wilson DC, Hwa J, Liu Y, Graeber M; Adapalene Study Group. Thiboutot D, et al. Among authors: poulin yp. J Am Acad Dermatol. 2006 Feb;54(2):242-50. doi: 10.1016/j.jaad.2004.10.879. J Am Acad Dermatol. 2006. PMID: 16443054 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

154 results

Search Page